Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

NCT00413660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

509

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
OTHER: placebo

Sponsor

Pfizer